Is a complete LON/0T6G research report available?

No complete published report is available for lon/0T6G (LON/0T6G) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LON/0T6G (LON/0T6G)

London Stock Exchange: LON/0T6G · USD

$15.0

-0.46 (-3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LON/0T6G analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	200.2M
Revenue (ttm)	40.7M
Net income (ttm)	25.2M
EPS (ttm)	$1.97
P/E (trailing)	8.0x
Volume	1,446
Beta	-0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 40.7M
Net income (ttm): 25.2M
EPS (ttm): $1.97
P/E (trailing): 8.0x
Market cap: 200.2M

All LON/0T6G indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	22
Employees Change	-17%
Employees Change Percent	-39.53
Enterprise value	$172.3M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US7469641051
Last refreshed	2026-07-30
Market cap	$200.2M
Price	$15.04
Price currency	USD
Rev Per Employee	1,849,786.32x
Sector	Healthcare
Sector PE	20.93
Sector PE Fwd	14.57
Sic	2836
Symbol	lon/0T6G
Website	https://www.q32bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.57%
EV Earnings	6.85x
EV/EBIT	10.71x
EV/EBITDA	9.79x
EV/Sales	4.27x
FCF yield	-10.3%
P/B ratio	5.71x
P/E ratio	7.95x
P/S ratio	4.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.84%
EBITDA Margin	40.51%
Gross margin	71.62%
Gross Profit	$29.1M
Net Income	$25.2M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	61.86%
Profit Margin	61.86%
Profit Per Employee	$1.1M
Profitable Years	1
ROA	18.75
ROCE	40.39
ROE	157.2
ROIC	35.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	586.28%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.75
Assets	$48.2M
Cash	$38.4M
Current Assets	$43.1M
Current Liabilities	$8M
Debt	$10.3M
Debt EBITDA	$0.58
Debt Equity	$0.29
Debt FCF	$-0.5
Equity	$35.1M
Interest Coverage	21.41
Liabilities	$13.1M
Long Term Assets	$5.2M
Long Term Liabilities	$5.1M
Net Cash	$28.1M
Net Cash By Market Cap	$14.03
Net Cash Growth	-20.52%
Net Debt EBITDA	$-1.7
Net Debt Equity	$-0.8
Tangible Book Value	$35.1M
Tangible Book Value Per Share	$2.4
WACC	2.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.36
Net Working Capital	$2.1M
Quick ratio	4.81
Working Capital	$35.2M
Working Capital Turnover	$0.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	585.37%
200-day SMA	6.27
50-day SMA	12.48
50-day SMA vs 200-day SMA	50over200
All Time High	53.4
All Time High Change	-71.68%
All Time High Date	2024-09-11
All Time Low	1.32
All Time Low Change	1,045.45%
All Time Low Date	2025-07-10
ATR	1.76
Beta	-0.27
Ch YTD	374.7
High	15.85
High52	23.5
High52 Date	2026-07-14
High52ch	-36%
Low	14.8
Low52	1.56
Low52 Date	2025-08-11
Low52ch	864.1%
Ma50ch	21.13%
Price vs 200-day SMA	141.15%
RSI	55.19
RSI Monthly	57.1
RSI Weekly	76.15
Sharpe ratio	1.75x
Sortino ratio	4.64
Total Return	-5.51%
Tr YTD	374.8
Tr1m	17.3%
Tr1w	-0.2%
Tr3m	167.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$16.2M
Operating margin	39.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-3,528,282.6
Shares Insiders	1.02%
Shares Institutions	24.85%
Shares Qo Q	11.93%
Shares Yo Y	5.51%
Short Ratio	1.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.7M
Adjusted OCF	-24,734,856.3
Average Volume	18,926.3x
Bv Per Share	2.4
Ch1m	17.3
Ch1w	-0.2
Ch1y	585.4
Ch3m	167.6
Ch6m	278
Change	-2.97%
Change From Open	-4.81
Close	15.5
Days Gap	1.94
Depreciation Amortization	272,448.4
Dollar Volume	21,747.8
Earnings Date	2026-08-06
EBIT	$16.2M
EBITDA	$16.5M
EPS	$1.97
F Score	4
FCF	$-20.6M
FCF EV Yield	-11.97x
Financing CF	4,295,434
Fiscal Year End	December
Founded	2,017
Graham Number	10.91091
Graham Upside	-29.61
Investing CF	5,301,135
Is Primary Listing	0
Last Earnings Date	2025-11-06
Last Report Date	2026-03-31
Ma150	7.42
Ma150ch	103.69%
Ma20	14.9
Ma20ch	1.45%
Net CF	-11,156,617
Next Earnings Date	2026-08-06
Open	15.8
Position In Range	22.86
Ppne	4,384,764.1
Price Date	2026-07-29
Price EBITDA	$12.15
Ptbv Ratio	5.71
Relative Volume	0.08x
Revenue	40,695,299x
SBC By Revenue	10.16x
Share Based Comp	4,135,643
Tr6m	278%
Volume	1,446
Z Score	-0.61

LON/0T6G (LON/0T6G)

Coverage state: Market snapshot only — no published research

Generate the first LON/0T6G analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0T6G

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0T6G indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/0T6G

Frequently asked questions